Private Equity Investments in Orthopedics Expected to Surge in 2019 — Avoid these risks
Law firm Foley & Lardner expects to see more private equity recapitalization transactions in orthopedics in 2019, according to JDSupra, and Provident Healthcare Partners Analyst Robert Aprill supports the prediction.
“Although the space has yet to see significant outside investment, there are a number of factors that make orthopedics a highly attractive opportunity for private equity groups,” Mr. Aprill said in a post. “Given the wide breadth of ancillary services offerings, increasing outpatient surgical volume, aging population and the growing importance of orthopedics to overall healthcare, there is significant opportunity in [the] space for private equity-led consolidation.”
To access the full article, click the following link: Private equity investments in orthopedics expected to surge in 2019 — Avoid these risks
About Becker’s ASC Review
Becker’s ASC Review features general business, legal and clinical guidance on topics relevant to outpatient surgery including joint-ventures, development and expansion, and regulatory and compliance issues; as well as analysis and insight for specialties including bariatrics, orthopedics and spine, gastroenterology, neurosurgery, ophthalmology, ENT and anesthesiology. Each of the nine annual issues of the publication reaches a qualified audience of more than 25,000 key ASC leaders, including surgeons, medical directors, directors of surgery and ASC administrators. Further, every ASC in the nation receives Becker’s ASC Review. Visit Becker’s ASC Review at https://www.beckersasc.com/.
